- Home
- DLHC vs ASRT Comparison
DLHC vs ASRT Comparison
Compare DLHC & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DLHC
- ASRT
- Stock Information
- Founded
- DLHC 1969
- ASRT 1995
- Country
- DLHC United States
- ASRT United States
- Employees
- DLHC N/A
- ASRT N/A
- Industry
- DLHC Business Services
- ASRT Biotechnology: Pharmaceutical Preparations
- Sector
- DLHC Consumer Discretionary
- ASRT Health Care
- Exchange
- DLHC Nasdaq
- ASRT Nasdaq
- Market Cap
- DLHC 79.7M
- ASRT 79.1M
- IPO Year
- DLHC N/A
- ASRT 1997
- Fundamental
- Price
- DLHC $5.93
- ASRT $0.81
- Analyst Decision
- DLHC
- ASRT Strong Buy
- Analyst Count
- DLHC 0
- ASRT 1
- Target Price
- DLHC N/A
- ASRT $3.00
- AVG Volume (30 Days)
- DLHC 32.4K
- ASRT 272.3K
- Earning Date
- DLHC 08-06-2025
- ASRT 08-11-2025
- Dividend Yield
- DLHC N/A
- ASRT N/A
- EPS Growth
- DLHC 80.25
- ASRT N/A
- EPS
- DLHC 0.31
- ASRT N/A
- Revenue
- DLHC $359,723,000.00
- ASRT $117,099,000.00
- Revenue This Year
- DLHC N/A
- ASRT N/A
- Revenue Next Year
- DLHC N/A
- ASRT $5.84
- P/E Ratio
- DLHC $18.18
- ASRT N/A
- Revenue Growth
- DLHC N/A
- ASRT N/A
- 52 Week Low
- DLHC $2.72
- ASRT $0.51
- 52 Week High
- DLHC $10.88
- ASRT $1.38
- Technical
- Relative Strength Index (RSI)
- DLHC 66.14
- ASRT 57.91
- Support Level
- DLHC $5.50
- ASRT $0.78
- Resistance Level
- DLHC $5.60
- ASRT $0.87
- Average True Range (ATR)
- DLHC 0.13
- ASRT 0.03
- MACD
- DLHC 0.04
- ASRT -0.00
- Stochastic Oscillator
- DLHC 100.00
- ASRT 47.36
About DLHC DLH Holdings Corp.
DLH Holdings Corp is a provider of technology-enabled business process outsourcing and program management solutions in the United States. The company offers services to several government agencies which include the Department of Veteran Affairs. The company is engaged in public health, performance evaluation, and health operations to solve the complex problems faced by civilian and military customers alike, leveraging digital transformation, artificial intelligence, analytics, cloud-based applications, telehealth systems, and others.
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.